ES2051733T3 - Procedimiento de obtencion de un medicamento a base de tamoxifen para uso local. - Google Patents

Procedimiento de obtencion de un medicamento a base de tamoxifen para uso local.

Info

Publication number
ES2051733T3
ES2051733T3 ES87301522T ES87301522T ES2051733T3 ES 2051733 T3 ES2051733 T3 ES 2051733T3 ES 87301522 T ES87301522 T ES 87301522T ES 87301522 T ES87301522 T ES 87301522T ES 2051733 T3 ES2051733 T3 ES 2051733T3
Authority
ES
Spain
Prior art keywords
procedure
obtaining
tamoxifen
local use
based medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87301522T
Other languages
English (en)
Spanish (es)
Inventor
Hans Alfred Kraus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of ES2051733T3 publication Critical patent/ES2051733T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES87301522T 1986-02-24 1987-02-23 Procedimiento de obtencion de un medicamento a base de tamoxifen para uso local. Expired - Lifetime ES2051733T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868604528A GB8604528D0 (en) 1986-02-24 1986-02-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2051733T3 true ES2051733T3 (es) 1994-07-01

Family

ID=10593569

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87301522T Expired - Lifetime ES2051733T3 (es) 1986-02-24 1987-02-23 Procedimiento de obtencion de un medicamento a base de tamoxifen para uso local.

Country Status (15)

Country Link
US (1) US4851433A (enExample)
EP (1) EP0240131B1 (enExample)
JP (1) JPH082789B2 (enExample)
AT (1) ATE79536T1 (enExample)
AU (1) AU603561B2 (enExample)
CA (1) CA1295946C (enExample)
DE (2) DE3781182T2 (enExample)
DK (1) DK173736B1 (enExample)
ES (1) ES2051733T3 (enExample)
GB (2) GB8604528D0 (enExample)
GR (1) GR3005445T3 (enExample)
IE (1) IE59568B1 (enExample)
IL (1) IL81573A (enExample)
NZ (1) NZ219374A (enExample)
ZA (1) ZA87884B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670160A (en) * 1990-08-24 1997-09-23 Schulke & Mayr Gmbh Preservatives and their use
US5189212A (en) * 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
WO1997036570A1 (de) * 1996-03-29 1997-10-09 S.W. Patentverwertungs Ges. M.B.H. Edelsbacher U. Partner Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der 'cellulite'
ATE214269T1 (de) * 1997-06-27 2002-03-15 Akzo Nobel Nv Oral anzuwendende flüssige arzneilösung
HUP0002852A3 (en) 1997-08-15 2001-11-28 Univ Durham A method of preventing or treating estrogen-dependent diseases and disorders using triphenil-ethylene derivatives
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733L (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
CZ20013912A3 (cs) 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
WO2006001035A2 (en) * 2004-06-28 2006-01-05 Lifecare Innovations Pvt. Ltd. Synergistic liposomal tamoxifen composition for topical application and method of preparing thereof.
EP3871693A1 (en) * 2005-09-27 2021-09-01 Special Water Patents B.V. Compositions for oral care
WO2012142029A2 (en) 2011-04-10 2012-10-18 Florida A&M University Serms for the treatment of estrogen receptor-mediated disorders
TW201919608A (zh) * 2017-09-11 2019-06-01 美商艾陶莎基因有限公司 局部用組合物
SG11202002105WA (en) 2017-09-11 2020-04-29 Atossa Therapeutics Inc Methods for making and using endoxifen
CN108938582A (zh) * 2018-07-13 2018-12-07 上海工程技术大学 一种枸橼酸他莫昔芬片剂及其制备方法
JP7662204B2 (ja) 2019-07-03 2025-04-15 アトッサ・セラピューティクス・インコーポレイテッド エンドキシフェンの徐放性組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (enExample) * 1962-09-13
US4061733A (en) * 1976-10-15 1977-12-06 Narayan Vishwanath Gunjikar Veterinary compositions for inducing estrus in animals and method
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee

Also Published As

Publication number Publication date
IE59568B1 (en) 1994-03-09
ZA87884B (en) 1987-10-28
JPH082789B2 (ja) 1996-01-17
GB2188547B (en) 1990-03-28
GR3005445T3 (enExample) 1993-05-24
GB2188547A (en) 1987-10-07
JPS62246515A (ja) 1987-10-27
CA1295946C (en) 1992-02-18
DE3781182T2 (de) 1992-12-17
IL81573A (en) 1991-04-15
US4851433A (en) 1989-07-25
DK71387A (da) 1987-08-25
EP0240131A3 (en) 1989-11-15
EP0240131B1 (en) 1992-08-19
DE3781182D1 (de) 1992-09-24
IE870280L (en) 1987-08-24
DK173736B1 (da) 2001-08-20
ATE79536T1 (de) 1992-09-15
NZ219374A (en) 1990-02-26
DK71387D0 (da) 1987-02-12
DE3705894A1 (de) 1987-08-27
AU603561B2 (en) 1990-11-22
EP0240131A2 (en) 1987-10-07
GB8604528D0 (en) 1986-04-03
AU6857887A (en) 1987-08-27
GB8704190D0 (en) 1987-04-01

Similar Documents

Publication Publication Date Title
ES2191682T3 (es) Nueva formulacion farmaceutica.
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
ES2160712T3 (es) Nueva preparacion farmaceutica para tratamiento del dolor.
SE8800731L (sv) Fenylkarbamat
ES482778A0 (es) Un procedimiento para la preparacion de una composicion u- til en el tratamiento de la epidermis.
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
ES2153820T3 (es) Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.
PT768867E (pt) Forma de dosagem para a administracao de droga em formulacao liquida
MX174161B (es) Una forma de dosis para suministrar el farmaco benefico verapamil
IT7823092A0 (it) Corpo di carbonio in forma di una placca, e procedimento per la sua fabbricazione.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
AR220901A1 (es) Procedimiento para la preparacion de nuevos derivados de espiro-hidantoina,utiles en el campo de la quimica medicinal
ES2185655T3 (es) Fracciones de acido aurintricarboxilico y analogos con actividad anti-angiogenica y metodos de uso.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
ES2054718T3 (es) El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica.
ES2195538T3 (es) Composicion farmaceutica que comprende una combinacion de isomeros dextro y levo de sotalol.
ES2125354T3 (es) Composicion a base de tandospirona o de sus analogos.
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
ES2152315T3 (es) Xamoneline tartrato.
IT990055B (it) Perfezionamento negli aspiratori per uso medicale
NO920255L (no) Podofyllotoksinpreparat som inneholder triglyserider

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 240131

Country of ref document: ES